Krisai Philipp, Johnson Linda S B, Moschovitis Giorgio, Benz Alexander, Ramasundarahettige Chinthanie, McIntyre William F, Wong Jorge A, Conen David, Sticherling Christian, Connolly Stuart J, Healey Jeff S
Cardiovascular Research Institute Basel, University Hospital Basel, Basel, Switzerland.
Electrophysiology and Ablation Unit and L'Institut de rythmologie et modélisation cardiaque (LIRYC), Centre hospitalier universitaire de Bordeaux, Bordeaux-Pessac, France.
CJC Open. 2021 Aug 8;3(12):1482-1489. doi: 10.1016/j.cjco.2021.07.016. eCollection 2021 Dec.
Heart failure (HF) is a frequent cause of hospitalization and death in patients with atrial fibrillation (AF). Identifying AF patients at risk of HF hospitalization could help select individuals for intensive follow-up and treatment.
We pooled data from 3 randomized trials (ACTIVE-A, RE-LY, AVERROES) of AF patients, for derivation and internal validation of a risk score for first HF hospitalization. Secondary endpoints were cardiovascular death and a composite of HF hospitalizations and cardiovascular death.
In 23,503 patients, the mean age was 71.3 years, and 62% were male. Over a mean follow-up of 2.0 years, 875 patients (3.7%) experienced their first HF hospitalization, and 1037 patients (4.4%) died from cardiovascular causes. Incidence rates per 100 patient-years were 1.85 for HF hospitalizations, 2.15 for cardiovascular death, and 3.71 for the composite. Independent predictors for HF hospitalizations included the following: increased age, weight, heart rate and serum creatinine level, lower height and systolic blood pressure, diabetes, vascular disease, valvular disease, heart rhythm, left ventricular hypertrophy, and intraventricular conduction delay. The C-statistic (95% confidence intervals by bootstrap simulations) was 0.717 (0.705-0.732). At 2 years of follow-up, the incidence rate of the primary outcome increased across risk-score quintiles: 0.49, 0.87, 1.29, 2.44, and 4.51 per 100 patient-years, respectively. Patients in the highest quintile had an absolute risk of 6.8% for the primary endpoint at 2 years.
In a large AF population, new-onset HF was common. A combination of characteristics can identify high-risk patients for whom strategies to prevent HF should be considered.
心力衰竭(HF)是心房颤动(AF)患者住院和死亡的常见原因。识别有HF住院风险的AF患者有助于选择进行强化随访和治疗的个体。
我们汇总了来自3项AF患者随机试验(ACTIVE-A、RE-LY、AVERROES)的数据,用于首次HF住院风险评分的推导和内部验证。次要终点是心血管死亡以及HF住院和心血管死亡的复合终点。
在23503例患者中,平均年龄为71.3岁,62%为男性。平均随访2.0年,875例患者(3.7%)首次发生HF住院,1037例患者(4.4%)死于心血管原因。每100患者年的发生率分别为:HF住院1.85例、心血管死亡2.15例、复合终点3.71例。HF住院的独立预测因素包括:年龄增加、体重、心率和血清肌酐水平升高,身高和收缩压降低,糖尿病、血管疾病、瓣膜疾病、心律、左心室肥厚和室内传导延迟。C统计量(通过自举模拟得到的95%置信区间)为0.717(0.705 - 0.732)。在随访2年时,主要结局的发生率在风险评分五分位数中呈上升趋势:每100患者年分别为0.49、0.87、1.29、2.44和4.51例。最高五分位数的患者在2年时主要终点的绝对风险为6.8%。
在大量AF人群中,新发HF很常见。多种特征组合可识别出应考虑采取预防HF策略的高危患者。